61st Annual SOT Meeting and ToxExpo Mar 27, 2022 20220327 Mar 31, 2022 San Diego, California/Virtual <p>The 61st SOT Annual Meeting&nbsp;and ToxExpo will have more than 2,000 presentations that will be delivered through Scientific Sessions, Continuing Education courses, Poster Sessions, and Exhibitor-Hosted Sessions. &nbsp;Most Scientific Sessions will be livestreamed, allowing for questions and answers from those on-site and remote attendees, as well as recorded for on-demand access by all registrants.</p> <p>Go to the conference website:&nbsp;<a href="https://www.toxicology.org/events/am/AM2022/index.asp" target="_blank">https://www.toxicology.org/events/am/AM2022/index.asp</a></p> /content/dam/pmiscience/default-fallback-thumbnails/conference/pmi-science-laboratory-work-3840x2160.jpg

      61st Annual SOT Meeting and ToxExpo

      Date
      Mar 27, 2022 - Mar 31, 2022
      Location
      San Diego, California/Virtual

      The 61st SOT Annual Meeting and ToxExpo will have more than 2,000 presentations that will be delivered through Scientific Sessions, Continuing Education courses, Poster Sessions, and Exhibitor-Hosted Sessions.  Most Scientific Sessions will be livestreamed, allowing for questions and answers from those on-site and remote attendees, as well as recorded for on-demand access by all registrants.

      Go to the conference website: https://www.toxicology.org/events/am/AM2022/index.asp

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.